90 results
10-K
2023 FY
EX-10.13
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2023 FY
EX-10.12
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2022 FY
EX-10.3
ATOS
Atossa Therapeutics Inc
Annual report
22 Mar 23
4:10pm
8-K
EX-10.1
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
i214n
5 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
iw2ya0piiz0w2ieqpjyj
27 May 16
Atossa Genetics Announces $10 Million At-the-Market
12:00am
8-K
EX-10.1
6l7n 5xct
20 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ryft95n5btc4ve
8 Feb 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
u118f86upj
16 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
8vmym
4 Sep 15
Announces Appointment of Scott Youmans as Chief Operating Officer
12:00am
8-K
EX-10.2
pyfnlis
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
zsa5exk5vwjkft
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
x4u244v
28 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
wjuxc
18 May 15
Entry into a Material Definitive Agreement
12:00am